Myers Randall 4
4 · LUMINEX CORP · Filed Jul 20, 2020
Insider Transaction Report
Form 4
LUMINEX CORPLMNX
Myers Randall
SVP, Global Mfg and Quality
Transactions
- Sale
Common Stock
2020-07-17$37.50/sh−12,848$481,800→ 34,138 total - Exercise/Conversion
Stock Option (Right To Buy)
2020-07-17$19.13/sh−18,771$359,089→ 0 totalExercise: $19.13From: 2017-03-22Exp: 2023-03-22→ Common Stock (18,771 underlying) - Sale
Common Stock
2020-07-17$37.50/sh−9,581$359,288→ 33,588 total - Exercise/Conversion
Stock Option (Right To Buy)
2020-07-17$19.13/sh−9,581$183,285→ 0 totalExercise: $19.13From: 2017-03-22Exp: 2023-03-22→ Common Stock (9,581 underlying) - Exercise/Conversion
Common Stock
2020-07-17$19.13/sh+9,581$183,285→ 43,169 total - Exercise/Conversion
Common Stock
2020-07-17$19.13/sh+18,771$359,089→ 52,359 total - Sale
Common Stock
2020-07-17$37.50/sh−18,771$703,913→ 33,588 total - Exercise/Conversion
Common Stock
2020-07-17$21.98/sh+12,848$282,399→ 46,436 total - Exercise/Conversion
Stock Option (Right To Buy)
2020-07-17$21.98/sh−12,848$282,399→ 12,849 totalExercise: $21.98From: 2019-03-12Exp: 2025-03-12→ Common Stock (12,848 underlying)
Footnotes (2)
- [F1]This sale is being made pursuant to a trading plan intended to comply with Rule 10b5-1 adopted by the seller on May 29, 2020. The representation regarding the seller's knowledge of material adverse non-public information speaks as of the date that the aforementioned trading plan was adopted.
- [F2]This balance includes a total of 550 shares obtained under the Luminex Corporation Employee Stock Purchase Plan on May 29, 2020.